An observational study in Severe Septic Syndrome and Septic Shock, sponsored by Rennes University Hospital. Terminated at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-02.
Sponsored by Rennes University Hospital · Observational
The aim of this project is to constitute a prospective cohort of all the patients presenting to the adult emergencies of the University Hospital Centre (CHU) of Rennes for a septic syndrome of community origin.
Severe septic syndrome (SSG) and septic shock (CS) are two frequent and serious complications of infectious diseases. In this context, the optimization of the management of septic patients from their reception in the emergency services must be a priority. However there are no predictors of progression or severity in patients admitted to emergencies despite the recommendations emphasizing the need for screening and early therapeutic management. Many scores have been proposed for intensive care unit but they remain difficult to extrapolate to other services because they are very comprehensive and require information that is difficult to obtain for emergency physicians.
Patient with a community infectious diseases
Exclusion Criteria:
Assessment of morbidity in patients with septic syndrome of community origin
Study of prognostic factors
Time frame: Day 90
Internal validity, severity score
Time frame: Day 90
Internal validity, triage score by orientation nurses
Time frame: Day 90
Study of the prognostic factors of patients with septic syndrome of community origin in terms of mortality
Time frame: Day 90
This study is terminated, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Systemic Inflammatory Response Syndrome→
Rennes University Hospital